Fibroblast growth factor 23 levels before and after renal transplantation
Background Fibroblast growth factor 23 (FGF23), a novel bone-derived hormone that inhibits phosphate reabsorption and calcitriol production by the kidney, has uncovered primary regulatory pathways and new systems biology governing bone mineralization, vitamin D metabolism, parathyroid gland function...
Main Authors: | Mohamed M El-khatib, Amal R El-Shahaby, Sahier O EEl-Khashab, Eman El Mohamed, Amr M Shaker |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2016-01-01
|
Series: | The Egyptian Journal of Internal Medicine |
Subjects: | |
Online Access: | http://www.esim.eg.net/article.asp?issn=1110-7782;year=2016;volume=28;issue=2;spage=52;epage=59;aulast=El-khatib |
Similar Items
-
Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
by: Michele F. Eisenga, et al.
Published: (2020-06-01) -
The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation Markers
by: Mohamed M. NasrAllah, et al.
Published: (2013-11-01) -
C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival
by: Chang Chu, et al.
Published: (2021-04-01) -
Role of the fibroblast growth factor type 23 in progression of complications and imbalance of calcium-phosphoric metabolism with patients suffering chronic kidney disease
by: A. M. Yesayan, et al.
Published: (2015-03-01) -
Study of graft survival rates of renal transplants in Cairo University Hospitals
by: Mohamed G Saadi, et al.
Published: (2016-01-01)